Two-Year Experience With Tacrolimus in Renal Transplantation After Late Conversion From Cyclosporine Therapy

Transplantation Proceedings

Volumn 41, Issue 6, 2009, Pages 2659-2663

  Videla, C O ^a  

^a Hospital Dr Gustavo Fricke   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; CREATININE; CYCLOSPORIN A; KETOCONAZOLE; SPIRONOLACTONE; T IMMUN; TACROLIMUS; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GINGIVA HYPERPLASIA; HUMAN; HYPERTRICHOSIS; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LONG TERM CARE; MALE; PRIORITY JOURNAL; PROTEINURIA;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; CADAVER; CREATININE; CYCLOSPORINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; GINGIVA; HUMANS; HYPERPLASIA; IMMUNOSUPPRESSIVE AGENTS; KETOCONAZOLE; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; LIPIDS; MALE; TACROLIMUS; TISSUE DONORS;

EID: 69149108659     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.06.075     Document Type: Article

References (17)

1. Webster A., Woodroffe R., Taylor R., et al. Tacrolimus versus cyclosporine as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomized trial data. BMJ 331 (2005) 810
2. Soltero L., Carbajal H., Rodríguez-Montalvo C., et al. Coadministration of tacrolimus and ketoconazole in renal transplant recipients: cost analysis and review of metabolic effects. Transplant Proc 35 (2003) 1319
3. Farouk El-Dahshan K., Adel Bakr M., Farouk Donia A., et al. Co-administration of ketoconazol to tacrolimus-treated kidney transplant recipients: a prospective randomized study. Nephrol Dial Transplant 19 (2004) 1613
4. Margreiter R., Pohanka E., Sparacino V., et al. Open prospective multicenter study of conversion to tacrolimus therapy in renal transplant patients experiencing cyclosporine-related side effects. Transplant Int 18 (2005) 816
5. Meier M., Nitschke M., Weidtmann B., et al. Slowing the progression of chronic allograft nephropathy by conversion from cyclosporine to tacrolimus: a randomized controlled trial. Transplantation 81 (2006) 1035
6. Cantarovich D., Renou M., Megnigbeto A., et al. Switching from cyclosporine to tacrolimus in patients with chronic transplant dysfunction or cyclosporine-induced adverse events. Transplantation 79 (2005) 72
7. Artz M., Boots J., Ligtenberg G., et al. Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile. Am J Transplant 4 (2004) 937
8. Cosio F., Amer H., Grande J., et al. Comparison of low versus high tacrolimus levels in kidney transplantation: assessment of efficacy by protocol biopsies. Transplantation 83 (2007) 411
9. Baid-Agrawal S., Delmonico F.L., Tolkoff-Rubin N., et al. Cardiovascular risk profile after conversion from cyclosporine A to tacrolimus in stable renal transplant recipients. Transplantation 77 (2004) 1199
10. Waid T., and CRAF Study Group. Tacrolimus as secondary intervention vs cyclosporine continuation in patients at risk for chronic renal allograft failure. Clin Ttrasplant 19 (2005) 573
11. Srinivas T., Meier Kriesche H.-U., and Kaplan B. Pharmacokinetic principles of immunosuppressive drugs. Am J Transpl 5 (2005) 207
12. MacPhee I.A.M., Fredericks S., Tai T., et al. The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation. Am J Transplant 4 (2004) 914
13. Rowshani A., Scholten E., Bemelman F., et al. No difference in degree of interstitial Sirius red-stained area in serial biopsies from area under concentration-over-time curves-guided cyclosporine versus tacrolimus-treated renal transplant recipients at one year. J Am Soc Nephrol 17 (2006) 305
14. Yamagata K., Ishida K., Sairencho T., et al. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int 71 (2007) 159
15. Videla C., Vega J., and Borja H. Prognostic meaning of proteinuria in kidney transplant [abstract]. Kidney Int 44 (1993) 1423
16. Lemahieu W., Meas B., Verbeke K., et al. Cytochrome P450 3A4 and P-glycoprotein activity and assimilation of tacrolimus in transplant patients with persistent diarrhea. Am J Transplant 5 (2005) 1383
17. Sato K., Amada N., Sato T., et al. Severe elevations of FK 506 blood concentration due to diarrhea in renal transplant recipients. Clin Transplant 18 (2004) 585